Insomnia Market Witnesses Robust Growth During the Forecast Period (2026-2036) with Emerging Orexin Receptor Antagonists and Melatonin Receptor Agonist | DelveInsight
The insomnia market is expected to increase throughout the study period due to several factors. Increased awareness of the disease has led to more cases being treated, contributing to market growth. Additionally, the rising number of clinical trials of therapies including Seltorexant...
The insomnia market is expected to increase throughout the study period due to several factors. Increased awareness of the disease has led to more cases being treated, contributing to market growth. Additionally, the rising number of clinical trials of therapies including Seltorexant...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.